The past quarter has been a busy and productive period for Y-InSiGHT, with continued growth in our activities aimed at connecting early-career researchers and clinicians, sharing emerging research, and raising awareness of hereditary gastrointestinal cancer research and patient advocacy.
Building engagement through webinars
Following the launch of the new Y-InSiGHT webinar series, two sessions have now been delivered. The inaugural webinar, held on 29 July 2026, featured Marc Greenblatt discussing variant curation and how the InSiGHT Variant Curation Expert Panel approaches the challenging question of whether a genetic variant is pathogenic.
The second webinar, held on 23 September 2026, focused on new genes and unsolved colorectal cancer, with Professor Dan Buchanan and Professor Maartje Nielsen. Both sessions are being made available online through the InSiGHT website for members, extending their value beyond the live events.
The next Y-InSiGHT webinar is planned for November 2026, focusing on vaccines in Lynch syndrome, with Professor David Church and Professor Matthias Kloor.
Launching the InSiGHT research podcast
Y-InSiGHT has also established a new InSiGHT research podcast, designed to bring recent research directly to the wider InSiGHT community through conversations with researchers and authors.
The first episode, released in July, discussed the recent paper “Prevalence and Consequences of APC Mosaicism in Patients With Colorectal Adenomas”, with Dr Diantha Terlouw and Professor Maartje Nielsen.
The second episode featured Professor Sir John Burn, discussing the first results from the CaPP3 trial, examining different aspirin doses for cancer prevention in people with Lynch syndrome.
The podcast is now available through Spotify and Apple Podcasts, providing another way for members to keep up with developments in hereditary gastrointestinal cancer research.
Continuing to raise awareness
Alongside these new educational initiatives, Y-InSiGHT has continued its social media and general communications activity, sharing research highlights, developments within InSiGHT and patient-advocacy content. This has helped increase the visibility of hereditary gastrointestinal cancer research while providing a platform for the wider community to engage with emerging work.
Y-InSiGHT will continue to develop its programme of educational and research activities over the coming months, creating opportunities for early-career members to engage with leading researchers, discuss emerging evidence and strengthen international collaboration within the hereditary gastrointestinal cancer community.